Type II methyltransferase PRMT5 has been reported to affect cancer biological functions in multiple manners, like histone methylation, inhibition of tumor suppressors or promotion of oncogenes, thus driving cancer cell growth, metastasis, and treatment resistance [23, 25, 26, 27]. Here, PRMT5 is linked to neoplasm.